LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Clinical trial NCT06216301 · RECRUITING

Trial details

NCT number: NCT06216301
Sponsor: NovoCure GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2024-07-31
Primary completion: 2028-10-01
Enrollment: 734

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.